Popel AS - Search Results

1

Anti-angiogenic peptides for cancer therapeutics.

Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS. Rosca EV, et al. Among authors: popel as. Curr Pharm Biotechnol. 2011 Aug;12(8):1101-16. doi: 10.2174/138920111796117300. Curr Pharm Biotechnol. 2011. PMID: 21470139 Free PMC article. Review.

2

Identification of novel short peptides derived from the alpha 4, alpha 5, and alpha 6 fibrils of type IV collagen with anti-angiogenic properties.

Karagiannis ED, Popel AS. Karagiannis ED, et al. Among authors: popel as. Biochem Biophys Res Commun. 2007 Mar 9;354(2):434-9. doi: 10.1016/j.bbrc.2006.12.231. Epub 2007 Jan 16. Biochem Biophys Res Commun. 2007. PMID: 17239819 Free PMC article.

3

Anti-angiogenic peptides identified in thrombospondin type I domains.

Karagiannis ED, Popel AS. Karagiannis ED, et al. Among authors: popel as. Biochem Biophys Res Commun. 2007 Jul 20;359(1):63-9. doi: 10.1016/j.bbrc.2007.05.041. Epub 2007 May 14. Biochem Biophys Res Commun. 2007. PMID: 17531201 Free PMC article.

4

Peptides derived from type I thrombospondin repeat-containing proteins of the CCN family inhibit proliferation and migration of endothelial cells.

Karagiannis ED, Popel AS. Karagiannis ED, et al. Among authors: popel as. Int J Biochem Cell Biol. 2007;39(12):2314-23. doi: 10.1016/j.biocel.2007.06.018. Epub 2007 Jul 30. Int J Biochem Cell Biol. 2007. PMID: 17707681 Free PMC article.

5

Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines.

Karagiannis ED, Popel AS. Karagiannis ED, et al. Among authors: popel as. J Cell Biochem. 2008 Jul 1;104(4):1356-63. doi: 10.1002/jcb.21712. J Cell Biochem. 2008. PMID: 18307172

6

A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells.

Karagiannis ED, Popel AS. Karagiannis ED, et al. Among authors: popel as. Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. doi: 10.1073/pnas.0803241105. Epub 2008 Sep 9. Proc Natl Acad Sci U S A. 2008. PMID: 18780781 Free PMC article.

7

A peptide derived from type 1 thrombospondin repeat-containing protein WISP-1 inhibits corneal and choroidal neovascularization.

Cano Mdel V, Karagiannis ED, Soliman M, Bakir B, Zhuang W, Popel AS, Gehlbach PL. Cano Mdel V, et al. Among authors: popel as. Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3840-5. doi: 10.1167/iovs.08-2607. Epub 2009 Mar 11. Invest Ophthalmol Vis Sci. 2009. PMID: 19279315

8

A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use.

Wu FT, Stefanini MO, Mac Gabhann F, Kontos CD, Annex BH, Popel AS. Wu FT, et al. Among authors: popel as. J Cell Mol Med. 2010 Mar;14(3):528-52. doi: 10.1111/j.1582-4934.2009.00941.x. Epub 2009 Oct 16. J Cell Mol Med. 2010. PMID: 19840194 Free PMC article. Review.

9

Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts.

Koskimaki JE, Karagiannis ED, Rosca EV, Vesuna F, Winnard PT Jr, Raman V, Bhujwalla ZM, Popel AS. Koskimaki JE, et al. Among authors: popel as. Neoplasia. 2009 Dec;11(12):1285-91. doi: 10.1593/neo.09620. Neoplasia. 2009. PMID: 20019836 Free PMC article.

10

Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model.

Koskimaki JE, Karagiannis ED, Tang BC, Hammers H, Watkins DN, Pili R, Popel AS. Koskimaki JE, et al. Among authors: popel as. BMC Cancer. 2010 Feb 1;10:29. doi: 10.1186/1471-2407-10-29. BMC Cancer. 2010. PMID: 20122172 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

330 results

Search Page